Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01688050 · ClinicalTrials.gov registry record · NA
TRANSFIX Zenith® Transection Clinical Study
A NA study, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01688050 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 50 participants.
The verdict
NCT01688050, a NA study, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The TRANSFIX study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® TX2® Low Profile Endovascular Graft for treatment of Blunt Thoracic Aortic Injury.
Interventions
- DEVICE Zenith® TX2® Low Profile Endovascular Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-01-23 |
| Est. Completion | 2019-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01688050
The ClinicalTrials.gov registry entry for NCT01688050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zenith® TX2® Low Profile Endovascular Graft is the first listed.
NCT01688050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01688050 about?
NCT01688050 is a clinical study titled "TRANSFIX Zenith® Transection Clinical Study". The TRANSFIX study is a clinical trial approved by US FDA to study the safety and effectiveness of the Zenith® TX2® Low Profile Endovascular Graft for treatment of Blunt Thoracic Aortic Injury.
What is the current status of trial NCT01688050?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-01-23. Estimated completion is 2019-07-29.
What interventions are being tested in trial NCT01688050?
The interventions under investigation include: Zenith® TX2® Low Profile Endovascular Graft (DEVICE).
Who is sponsoring clinical trial NCT01688050?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.